-
Interview Series 20 Mar 2026
From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan
-
Interview Series 20 Mar 2026
From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester
-
Interview Series 20 Mar 2026
From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.
-
Interview Series 20 Mar 2026
From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
-
Interview Series 20 Mar 2026
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
-
Interview Series 20 Mar 2026
From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.
-
Interview Series 20 Mar 2026
From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu
-
Interview Series 20 Mar 2026
From the helm: 4DMedical (ASX:4DX), Founder & CEO, Andreas Fouras.
-
Interview Series 20 Mar 2026
From the helm: EBR Systems (ASX:EBR), President & CEO, John McCutcheon
-
Interview Series 15 Dec 2025
From the helm: Blackpearl Group Limited (ASX:BPG), Nick Lissette, CEO
-
Interview Series 29 Oct 2025
From the Helm: Rural Funds Group (ASX:RFF), Tim Sheridan, COO & James Powell, GM
-
Interview Series 28 Oct 2025
From the helm: SenSen Networks Limited (ASX: SNS), Dr Subhash Challa, CEO
